Agios Global Medical Affairs LinkedIn and X Community Guidelines
- Thank you for following our Agios Global Medical Affairs LinkedIn and X channels. Our social media pages are dedicated to communicating emerging, trusted scientific information to healthcare professionals (HCPs). The LinkedIn page is intended for global HCP audiences and the X page is intended for US HCP audiences only. The Agios Medical LinkedIn and X channels are brought to you by Agios Pharmaceuticals, Inc. For more information on Agios Medical, please visit: agios.com/medical
We have created guidelines to ensure compliance with the regulations of our industry as well as the Terms of Use of LinkedIn and X.
- By following Agios Medical, you confirm that you are a healthcare professional and agree to receive information relating to scientific data supported by Agios Medical.
- Please be advised that our page respects and follows all guidelines set forth by the Agios Privacy Policy, LinkedIn Privacy Policy, and X Privacy Policy. Therefore, we reserve the right to report posts that we believe are in breach of the general LinkedIn and X rules and regulations.
- While Agios appreciates all comments, please note that we operate within a highly regulated environment and not every comment may be acknowledged or addressed.
- Our LinkedIn and X pages are public; therefore, we recommend that you do not share personal information on them (i.e., address, phone number, etc.).
- We cannot respond to mentions, replies, or direct messages that cite product names. We ask that our followers refrain from posting information related to medicines on our page. If you have a question about a specific Agios medication, please contact Agios’ Medical Information department at: medinfo@agios.com.
- The information provided on our channels is for educational purposes only. Further, we cannot offer health or medical advice and ask that our followers refrain from posting medical advice of any nature on our LinkedIn and X feeds.
- LinkedIn and X accounts that Agios follows or are followed by do not indicate Agios’ endorsement of these accounts or the content they produce. While we may post links to third-party sites, Agios does not endorse and is not responsible for the content on those websites.
- Posts and links from LinkedIn and X users are not created or controlled by Agios, and Agios is not responsible for such content.
- Profanity or defamatory, libelous, offensive, abusive, discriminatory, or demeaning content will not be tolerated. Please treat each other with respect.
- By posting content to our page, you grant Agios Medical an irrevocable, perpetual, nonexclusive, fully paid, sublicensable worldwide license to use that content for any purpose, including marketing and promotion. This includes a right to modify, edit, crop, highlight, and/or republish your content.
- To report an adverse event (AE) or product complaint (PC) related to an Agios product, please contact: medinfo@agios.com.
- Agios reserves the right to change the terms and conditions of these guidelines at any time.
If your post was removed from our page, it could be for one of the following reasons:
- Your comment mentions a product or medicine. Industry standards require that all discussions regarding pharmaceutical products are supported by clinical data and represent fair balance. As we cannot guarantee that all user-generated content will represent fair balance, brand mentions will be removed.
- Your comment references an Adverse Event (AE) or Product Complaint (PC). If your post mentions or insinuates an AE or PC related to an Agios treatment, we may be required to contact you for further information. While your post will be removed, Agios may be required to report the relevant information to the FDA. If you prefer, you may contact the FDA directly at: fda.gov/medwatch or call 1-800-FDA-1088.
- Your comment contains vulgarity. Any post containing profane/vulgar language, personal attacks, or offensive terms that target specific age, gender-orientation, ethnic, racial or religious groups will be immediately removed.
- Your comment contains medical advice. Unsolicited and unverified medical advice may carry serious implications. Therefore, any post containing such information will be deleted.
- Your comment is off topic. While we appreciate engagement on our page, content that is clearly off-topic or considered spam will be promptly removed.
- Other reasons. There may be a unique situation or circumstance that warrants the removal of LinkedIn and X content from our page. If you believe your content was unfairly removed from our page, please contact us and we will revisit the action to determine if it was done unjustly.
Copyright © 2024 Agios Pharmaceuticals, Inc. All rights reserved.